[Hemodynamic and coronary changes induced by various slow-channel inhibitors in chronic coronary insufficiency: nifedipine, verapamil and bepridil].
D000328:Adult; D000368:Aged; D015764:Bepridil; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D007473:Ion Channels; D011759:Pyrrolidines; D015764:Bepridil; D014700:Verapamil; D009543:Nifedipine
Modifications hémodynamiques et coronaires induites par différents inhibiteurs des canaux lents dans l'insuffisance coronaire chronique: la nifédipine, le vérapamil et le bépridil.